Skip to content

Sidestream Dark-Field (SDF) Imaging of the Intestinal Microcirculation

Sidestream Dark-Field Imaging of the Intestinal Microcirculation in Clinical Sepsis: The Impact of Activated Protein C Therapy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00883597
Enrollment
36
Registered
2009-04-17
Start date
2011-11-30
Completion date
2023-12-01
Last updated
2024-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Brief summary

Sepsis is the most frequent cause of death in critically ill patients in non-coronary care Intensive Care Units in the developed world. Microcirculatory disturbances are central to the development of the disorder, leading to organ dysfunction, multi-organ failure and fatal outcome. In particular the intestinal microcirculation is impaired early in the course of the disease. This may result in a breakdown of the gut barrier function with translocation of bacteria and their toxins into the systemic circulation, thus sustaining a gut derived septic state. Therefore, the impaired intestinal microcirculation has been suggested to act as the motor of multiple organ failure in sepsis. The aim of the project is to evaluate a new diagnostic tool and the impact of Activated Protein C administration on the intestinal microcirculation in patients with severe sepsis and compare the findings with septic patients who are not candidates for APC therapy and healthy patients post bowel surgery using an innovative diagnostic tool (side stream dark-field imaging, SDF).

Interventions

None listed

Sponsors

Nova Scotia Health Research Foundation
CollaboratorOTHER_GOV
Nova Scotia Health Authority
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ileostomy, no infection at the site of stoma, informed consent. * diagnosed sepsis according to American College of Chest Physicians/Society of Critical Care Medicine criteria13. * indication for treatment according to hospital guidelines

Exclusion criteria

* infection at the site of stoma, * moribund patients

Design outcomes

Primary

MeasureTime frame
Microvascular Flow Index (MFI)6 hours after treatment

Secondary

MeasureTime frame
Leukocyte - endothelial cell interactions, red blood cell velocity6 hours after treatment

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026